Functional characterization of a novel variant of estrogen receptor beta identified in screening of DNA derived from African Americans.
Information on single nucleotide polymorphisms in the estrogen receptor beta (ERbeta) gene is lacking for the African American population. In this study, we systematically screened the coding and flanking intron regions of the ERbeta gene in 49 healthy African American individuals. We detected four novel variants, of which one variant (963T-->C) resulted in amino acid change from phenylalanine to leucine at position 289, referred to as ERbetaF289L. This receptor variant was characterized in vitro for transcriptional activity and ligand-binding. These studies revealed that ERbetaF289L had reduced estrogen binding affinity and impaired response to 17beta-estradiol induced transactivation compared to the wild-type ERbeta. This novel variant might confer genetic susceptibility to certain endocrine related diseases in African Americans.